-
Advanced Breast Cancer at Diagnosis Linked to 10% Higher CVD Risk
08 Feb 2025 00:29 GMT
… locally advanced or metastatic breast cancer at diagnosis (OR … advanced or metastatic breast cancer at diagnosis … breast cancers and were more likely to [experience a] spread of that breast cancer … breast cancer and most of this effect [with breast cancer …
-
KN026 Plus Docetaxel Demonstrates Efficacy in HER2+ Metastatic Breast Cancer
07 Feb 2025 19:09 GMT
… HER2-positive recurrent/metastatic breast cancer is pertuzumab (Perjeta) plus … with HER2-positive, recurrent, metastatic breast cancer were enrolled onto the … patients with HER2-positive recurrent-metastatic breast cancer. Subsequent large, randomized …
-
Dr Krop on Zanidatamab Plus Evorpacept in HER2+ Metastatic Breast Cancer
07 Feb 2025 19:09 GMT
… HER2-positive and HER2-low metastatic breast cancer (mBC), presented at the 2024 … San Antonio Breast Cancer Symposium (SABCS).
In this open … pretreated patients with HER2-positive breast cancer. Continued research will be essential …
-
The Prediction Model of High-Frequency Ultrasound Combined with Artificial Intelligence-Assisted Scoring System Improved the Diagnosis of Sclerosing Adenosis and Early Breast Cancer
07 Feb 2025 09:01 GMT
… breast cancer,10 and no metastasis or distant metastasis … Family history of breast cancer; Ultrasonic characteristic parameters … and risk of breast cancer. Breast Cancer Res Treat. 2014 … of bilateral breast cancer occurrence. Clin Breast Cancer. 2012;12 …
-
Gilead’s breast cancer treatment Trodelvy passes drug reimbursement panel
07 Feb 2025 06:24 GMT
… #39;s triple-negative breast cancer treatment Trodelvy (trastuzumab govitecan … ’s triple-negative breast cancer drug Trodelvy
It is … used for triple-negative breast cancer patients,” HIRA said. … or subsequent treatment of metastatic or recurrent clear cell …
-
Registration opens for 2025 Tiffany's Pink Pedal Ride to raise funds for breast cancer research and survivor resources
07 Feb 2025 00:52 GMT
… to provide financial support to breast cancer research organizations and other nonprofits … joyful life was taken by metastatic breast cancer in 2023 at the age … to provide financial contributions to breast cancer research organizations and to non …
-
Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
06 Feb 2025 23:46 GMT
… hormone receptor-positive, HER2– metastatic breast cancer and also included patients with … drug conjugates come in for metastatic breast cancer in HR-positive setting, … for unresectable or metastatic, HR-positive, HER2-negative breast cancer. News release. …
-
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
06 Feb 2025 20:43 GMT
… high risk of progression to metastatic disease, higher incidence in younger … or III TNBC experience a metastatic recurrence, despite receiving the best … Patients With Operable Triple-Negative Breast Cancer (IMpassion030). ClinicalTrials.gov. Updated August …
-
FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HR-positive, HER2-low or HER2-ultralow breast cancer
06 Feb 2025 20:35 GMT
… with membrane staining) breast cancer, as determined by an … 0 with membrane staining) breast cancer for treatment with Enhertu … with advanced or metastatic HR-positive breast cancer with HER2-low … with HER2-low breast cancer assessed by blinded independent …
-
Why Breast cancer survivors are at a higher risk of heart disease
06 Feb 2025 20:24 GMT
… an important message with breast cancer survivors.
They might face … type of cancer called metastatic melanoma. This was discovered … about my heart."
Breast cancer survivors like Rutherford are … the risk of death from breast cancer," Bottinor said.
…